بدائل البحث:
teer decrease » greater decrease (توسيع البحث)
we decrease » _ decrease (توسيع البحث), nn decrease (توسيع البحث), use decreased (توسيع البحث)
a decrease » _ decrease (توسيع البحث), _ decreased (توسيع البحث), _ decreases (توسيع البحث)
teer decrease » greater decrease (توسيع البحث)
we decrease » _ decrease (توسيع البحث), nn decrease (توسيع البحث), use decreased (توسيع البحث)
a decrease » _ decrease (توسيع البحث), _ decreased (توسيع البحث), _ decreases (توسيع البحث)
-
16941
DataSheet_1_Photosynthetic Mechanisms of Metaxenia Responsible for Enlargement of Carya cathayensis Fruits at Late Growth Stages.docx
منشور في 2020"…We observed the photosynthetic capacity in the peel of fruits and the related ecophysiological and morphological traits of both ph and pp fruits over a period of 120 days after pollination. Significant differences in the appearance and dry weight between ph and pp fruits were observed at 50 days after pollination (DAP). …"
-
16942
-
16943
-
16944
-
16945
-
16946
-
16947
Video_5_Identification of TH Variants in Chinese Dopa-Responsive Dystonia Patients and Long-Term Outcomes.MP4
منشور في 2021"…<p>Background: Dopa-responsive dystonia (DRD) is a movement disorder that is highly clinically and genetically heterogeneous. …"
-
16948
-
16949
-
16950
-
16951
DataSheet_1_Photosynthetic Mechanisms of Metaxenia Responsible for Enlargement of Carya cathayensis Fruits at Late Growth Stages.docx
منشور في 2020"…We observed the photosynthetic capacity in the peel of fruits and the related ecophysiological and morphological traits of both ph and pp fruits over a period of 120 days after pollination. Significant differences in the appearance and dry weight between ph and pp fruits were observed at 50 days after pollination (DAP). …"
-
16952
-
16953
-
16954
-
16955
Table8_Indications and adverse events of teriparatide: based on FDA adverse event reporting system (FAERS).DOCX
منشور في 2024"…</p>Results<p>Out of 107,123 reports with teriparatide as the primary suspect, key AEs identified included pain in extremity (PRR: 4.54), muscle spasms (PRR: 5.11), fractures (PRR range: 17.67–552.95), and increased calcium levels (PRR: 50.73). Teriparatide exhibited a stronger association with increased calcium levels (PRR: 50.73) compared to fractures (PRR range: 17.67–552.95). …"
-
16956
Table1_Indications and adverse events of teriparatide: based on FDA adverse event reporting system (FAERS).XLSX
منشور في 2024"…</p>Results<p>Out of 107,123 reports with teriparatide as the primary suspect, key AEs identified included pain in extremity (PRR: 4.54), muscle spasms (PRR: 5.11), fractures (PRR range: 17.67–552.95), and increased calcium levels (PRR: 50.73). Teriparatide exhibited a stronger association with increased calcium levels (PRR: 50.73) compared to fractures (PRR range: 17.67–552.95). …"
-
16957
Table2_Indications and adverse events of teriparatide: based on FDA adverse event reporting system (FAERS).DOCX
منشور في 2024"…</p>Results<p>Out of 107,123 reports with teriparatide as the primary suspect, key AEs identified included pain in extremity (PRR: 4.54), muscle spasms (PRR: 5.11), fractures (PRR range: 17.67–552.95), and increased calcium levels (PRR: 50.73). Teriparatide exhibited a stronger association with increased calcium levels (PRR: 50.73) compared to fractures (PRR range: 17.67–552.95). …"
-
16958
-
16959
-
16960